Financhill
Buy
67

MLAB Quote, Financials, Valuation and Earnings

Last price:
$119.96
Seasonality move :
6.6%
Day range:
$125.73 - $129.61
52-week range:
$83.68 - $155.12
Dividend yield:
0.5%
P/E ratio:
--
P/S ratio:
2.90x
P/B ratio:
4.44x
Volume:
49.3K
Avg. volume:
45.8K
1-year change:
9.09%
Market cap:
$689.7M
Revenue:
$216.2M
EPS (TTM):
-$46.26

Earnings Data

Next earnings date for MLAB
Jun 05
2025
Most recent earnings per share
-$0.31
Missed by $1.82
(Feb 4/2025)
Consensus Estimate
$1.51
(Feb 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MLAB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $60.8M -- -- $1.87 --
06/05/2025 Q1 $61.9M -- -- $2.07 --
02/04/2025 Q4 $58.8M $62.8M -$0.31 $1.51 -$1.82
11/07/2024 Q3 $57.5M $57.8M $0.63 $1.38 -$0.75
08/05/2024 Q2 $55.7M $58.2M $0.62 $1.55 -$0.93
06/05/2024 Q1 $55.3M $58.9M -$47.20 $1.75 -$48.95
02/05/2024 Q4 $54.6M $53.5M $0.39 $1.70 -$1.31
11/06/2023 Q3 -- -- -$0.23 $1.79 -$2.02
08/03/2023 Q2 -- -- -$0.10 $1.36 -$1.46
05/25/2023 Q1 -- -- $0.11 $1.69 -$1.58
02/06/2023 Q4 -- -- $0.08 $1.58 -$1.50
11/03/2022 Q3 -- -- $0.24 $1.16 -$0.92
08/04/2022 Q2 -- -- -$0.27 $1.47 -$1.74
05/31/2022 Q1 -- -- -$0.34 $1.80 -$2.14
02/03/2022 Q4 -- -- -$0.39 $1.32 -$1.71
11/04/2021 Q3 -- -- $0.70 $1.07 -$0.37
08/05/2021 Q2 -- -- $0.38 $1.02 -$0.64
06/01/2021 Q1 -- -- $0.74 $1.07 -$0.33
02/03/2021 Q4 -- -- -$0.89 $1.04 -$1.93
11/05/2020 Q3 -- -- $0.51 $1.07 -$0.56
08/06/2020 Q2 -- -- $0.22 $1.78 -$1.56
06/01/2020 Q1 -- -- -$0.38 $0.67 -$1.05
02/10/2020 Q4 -- -- -$1.06 $1.53 -$2.59
11/06/2019 Q3 -- -- $0.71 $1.36 -$0.65
07/30/2019 Q2 -- -- $1.13 $1.45 -$0.32
06/03/2019 Q1 -- -- $0.35 $1.68 -$1.33
02/04/2019 Q4 -- -- $0.21 $1.45 -$1.24
10/31/2018 Q3 -- -- $0.25 $1.38 -$1.13
07/31/2018 Q2 -- -- $1.06 -- --
06/05/2018 Q1 -- -- $1.08 -- --
02/05/2018 Q4 -- -- -$2.93 -- --
11/06/2017 Q3 -- -- $0.60 -- --
08/01/2017 Q2 -- -- $0.39 -- --
06/07/2017 Q1 -- -- $0.94 -- --
02/02/2017 Q4 -- -- $0.84 -- --
11/02/2016 Q3 -- -- $0.62 -- --
07/28/2016 Q2 -- -- $0.51 -- --
06/06/2016 Q1 -- -- $1.06 -- --
02/02/2016 Q4 -- -- $0.69 -- --
11/02/2015 Q3 -- -- $0.48 -- --
08/03/2015 Q2 -- -- $0.74 -- --

Mesa Laboratories Earnings Questions

  • How Much did Mesa Laboratories Generate in Revenue Last Quarter?

    Mesa Laboratories reported $62.8M worth of top line sales in its most recent quarter.

  • Did Mesa Laboratories Beat Earnings Last Quarter?

    Mesa Laboratories announced earnings per share of -$0.31 which represents a miss of analyst forecast a $1.51 per share.

  • Is Mesa Laboratories Profitable?

    Mesa Laboratories reported $39.8M that represents $7.32 per share over the last quarter.

  • What is the Analyst Consensus for Mesa Laboratories EPS Next Year?

    Mesa Laboratories's earnings are forecast to grow from -$47.20 per share to $7.77 per share next year representing an increase of 4364.71%.

  • When is Mesa Laboratories's Earnings Date?

    Mesa Laboratories's next earnings date is June 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.72% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock